Bioengineered Blood Vessels Show Promise in Trauma Care
First human trials at Rutgers Health and other institutions demonstrate better infection resistance and limb preservation ...
Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
Symvess is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial ...